C-type natriuretic peptide: a potential marker of chronic kidney disease in diabetes
There is an urgent need for an early test for diabetic kidney disease enabling beneficial interventions before irreversible kidney damage occurs. A new test developed in Christchurch measures NTproCNP in urine, which increases when the kidneys are injured, and may prove to be a useful early marker of kidney injury.
Associate Professor Lunt is currently a Diabetes Physician at the Christchurch Diabetes Centre, a Clinical Director of the Health Innovation Hub at the Canterbury District Health Board, and a Clinical Associate Professor at the University of Otago, Christchurch.
More About Associate Professor Helen Lunt